Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression
Acute pancreatitis (AP) is one of the leading causes of hospital admission, 20% of which could progress to the severe type with extensive acinar cell necrosis. Clinical studies have reported that diabetes is an independent risk factor of the incidence of AP and is associated with higher severity tha...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/5123823 |
id |
doaj-5a01541a83924764b3cda0099e15d396 |
---|---|
record_format |
Article |
spelling |
doaj-5a01541a83924764b3cda0099e15d3962021-09-06T00:00:41ZengHindawi LimitedJournal of Immunology Research2314-71562021-01-01202110.1155/2021/5123823Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis ProgressionXiao-Min Luo0Cen Yan1Yue-Jie Zhang2Ling-Jia Meng3Guo-Tao Lu4Ji-Ming Yin5Ying-Mei Feng6Department of Science and TechnologyDepartment of Science and TechnologyDepartment of Science and TechnologyDepartment of Science and TechnologyPancreatic CenterBeijing Hepatology InstituteDepartment of Science and TechnologyAcute pancreatitis (AP) is one of the leading causes of hospital admission, 20% of which could progress to the severe type with extensive acinar cell necrosis. Clinical studies have reported that diabetes is an independent risk factor of the incidence of AP and is associated with higher severity than nondiabetic subjects. However, how diabetes participates in AP progression is not well defined. To investigate this question, wild-type (wt) and diabetic db/db mice at the age of 16 weeks were used in the study. AP was induced in wt recipients by 10 injections of 50 μg/kg caerulein with a 1 h interval. One hour after the last caerulein injection, bone marrow cells (BMC) isolated from wt and db/db mice were injected intraperitoneally into the recipients (1×107cells/recipient). The recipients with no BMC injection served as controls. Thirteen hours after BMC injection, serum lipase activity was 1.8- and 1.3-folds higher in mice that received db/db BMC, compared with those with no injection and wt BMC injection, respectively (p≤0.02 for both). By H&E staining, the overall severity score was 14.7 for no cell injection and 16.6 for wt BMC injection and increased to 22.6 for db/db BMC injection (p≤0.002 for both). In particular, mice with db/db BMC injection developed more acinar cell necrosis and vacuolization than the other groups (p≤0.03 for both). When sections were stained with an antibody against myeloperoxidase (MPO), the density of MPO+ cells in pancreatitis was 1.9- and 1.6-folds higher than wt BMC and no BMC injection groups, separately (p≤0.02 for both). Quantified by ELISA, db/db BMC produced more IL-6, GM-CSF, and IL-10 compared with wt BMC (p≤0.04 for all). In conclusion, BMC of db/db mice produced more inflammatory cytokines. In response to acinar cell injury, diabetic BMC aggravated the inflammation cascade and acinar cell injury, leading to the progression of acute pancreatitis.http://dx.doi.org/10.1155/2021/5123823 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiao-Min Luo Cen Yan Yue-Jie Zhang Ling-Jia Meng Guo-Tao Lu Ji-Ming Yin Ying-Mei Feng |
spellingShingle |
Xiao-Min Luo Cen Yan Yue-Jie Zhang Ling-Jia Meng Guo-Tao Lu Ji-Ming Yin Ying-Mei Feng Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression Journal of Immunology Research |
author_facet |
Xiao-Min Luo Cen Yan Yue-Jie Zhang Ling-Jia Meng Guo-Tao Lu Ji-Ming Yin Ying-Mei Feng |
author_sort |
Xiao-Min Luo |
title |
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression |
title_short |
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression |
title_full |
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression |
title_fullStr |
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression |
title_full_unstemmed |
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression |
title_sort |
diabetic bone marrow cell injection accelerated acute pancreatitis progression |
publisher |
Hindawi Limited |
series |
Journal of Immunology Research |
issn |
2314-7156 |
publishDate |
2021-01-01 |
description |
Acute pancreatitis (AP) is one of the leading causes of hospital admission, 20% of which could progress to the severe type with extensive acinar cell necrosis. Clinical studies have reported that diabetes is an independent risk factor of the incidence of AP and is associated with higher severity than nondiabetic subjects. However, how diabetes participates in AP progression is not well defined. To investigate this question, wild-type (wt) and diabetic db/db mice at the age of 16 weeks were used in the study. AP was induced in wt recipients by 10 injections of 50 μg/kg caerulein with a 1 h interval. One hour after the last caerulein injection, bone marrow cells (BMC) isolated from wt and db/db mice were injected intraperitoneally into the recipients (1×107cells/recipient). The recipients with no BMC injection served as controls. Thirteen hours after BMC injection, serum lipase activity was 1.8- and 1.3-folds higher in mice that received db/db BMC, compared with those with no injection and wt BMC injection, respectively (p≤0.02 for both). By H&E staining, the overall severity score was 14.7 for no cell injection and 16.6 for wt BMC injection and increased to 22.6 for db/db BMC injection (p≤0.002 for both). In particular, mice with db/db BMC injection developed more acinar cell necrosis and vacuolization than the other groups (p≤0.03 for both). When sections were stained with an antibody against myeloperoxidase (MPO), the density of MPO+ cells in pancreatitis was 1.9- and 1.6-folds higher than wt BMC and no BMC injection groups, separately (p≤0.02 for both). Quantified by ELISA, db/db BMC produced more IL-6, GM-CSF, and IL-10 compared with wt BMC (p≤0.04 for all). In conclusion, BMC of db/db mice produced more inflammatory cytokines. In response to acinar cell injury, diabetic BMC aggravated the inflammation cascade and acinar cell injury, leading to the progression of acute pancreatitis. |
url |
http://dx.doi.org/10.1155/2021/5123823 |
work_keys_str_mv |
AT xiaominluo diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT cenyan diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT yuejiezhang diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT lingjiameng diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT guotaolu diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT jimingyin diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression AT yingmeifeng diabeticbonemarrowcellinjectionacceleratedacutepancreatitisprogression |
_version_ |
1717780260662018048 |